Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres.

Polymer microspheres capable of the controlled release of macromolecules for periods ranging from days to over a month were developed. The microspheres were made using a new family of anhydride polymers: tyrosine-containing poly(anhydride-co-imides), specifically poly[trimellitylimido-L-tyrosine-co-sebacic acid-co-1,3-bis(carboxphenoxy)propane] anhydrides [poly(TMA-Tyr:SA:CPP)]. These polymers may be of particular interest for controlled delivery of vaccine antigens due to the incorporation of an immunological adjuvant, L-tyrosine, into their backbone. Microspheres were produced from a variety of polymer compositions using a double-emulsion solvent-evaporation technique, and tested for their ability to provide controlled release of a model protein, bovine serum albumin, in vitro. The microspheres are spherical with smooth surfaces and encapsulate greater than 70% of the protein. Protein release rates from polymers of identical composition could be varied from 0.3 to over 125 micrograms per mg spheres per month by changing the amount of protein encapsulated. This effect can be magnified by using polymers with various monomer ratios. A close correlation between protein release and polymer weight loss was observed, suggesting a release mechanism controlled mainly by polymer erosion. Bovine serum albumin release from poly(TMA-Tyr:SA:CPP) microspheres is also pH sensitive, being enhanced at high pH and depressed under acidic conditions.

[1]  M. Donbrow,et al.  Microcapsules and Nanoparticles in Medicine and Pharmacy , 1991 .

[2]  R. Langer,et al.  A single-step immunization by sustained antigen release. , 1979, Journal of immunological methods.

[3]  R. Langer,et al.  Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers , 1990 .

[4]  E. Mathiowitz,et al.  A microtensiometer for the analysis of bioadhesive microspheres. , 1995, Biomedical instrumentation & technology.

[5]  Robert Langer,et al.  Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation , 1987 .

[6]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.

[7]  D. O’hagan.  Novel Delivery Systems for Oral Vaccines , 1994 .

[8]  Paul J. Flory,et al.  Thermodynamics of Crystallization in High Polymers. I. Crystallization Induced by Stretching , 1947 .

[9]  S. Arya.  Human immunization in developing countries: practical and theoretical problems and prospects. , 1994, Vaccine.

[10]  M. Powell,et al.  Vaccine Design , 1995, Pharmaceutical Biotechnology.

[11]  R. Langer,et al.  Polymer microspheres for vaccine delivery. , 1995, Pharmaceutical biotechnology.

[12]  R. Langer,et al.  Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. , 1998, Biomaterials.

[13]  J. Fox,et al.  Evaluation of ethylene-vinyl acetate copolymer as a non-inflammatory alternative to Freund's complete adjuvant in rabbits. , 1985, Laboratory animal science.

[14]  A. Wheeler,et al.  Adjuvant properties of hydrophobic derivatives prepared from L-tyrosine. , 1984, International archives of allergy and applied immunology.

[15]  C. Bona,et al.  Further studies on the adjuvanticity of stearyl tyrosine and amide analogues. , 1994, Vaccine.

[16]  Y. Ikada,et al.  Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.

[17]  H. Winn,et al.  Intracerebral drug delivery in rats with lesion-induced memory deficits. , 1989, Journal of neurosurgery.

[18]  R Langer,et al.  Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of biomedical materials research.

[19]  R. Langer,et al.  Synthesis and Characterization of Degradable Anhydride-co-imide Terpolymers Containing Trimellitylimido-l-tyrosine: Novel Polymers for Drug Delivery , 1996 .

[20]  J C Murphy,et al.  Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity. , 1986, Journal of immunological methods.

[21]  K. Rock,et al.  Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Glenny,et al.  Rate of Disappearance of Diphtheria Toxoid injected into Rabbits and Guinea-Pigs: Toxoid precipitated with Alum. , 1931 .

[23]  R. Langer,et al.  Biodegradable polymers as drug delivery systems , 1990 .

[24]  K. Mills,et al.  Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. , 1995, Vaccine.

[25]  Rajesh K. Gupta,et al.  Adjuvants--a balance between toxicity and adjuvanticity. , 1993, Vaccine.

[26]  A. Wheeler,et al.  l-Tyrosine as an immunological adjuvant. , 1982, International archives of allergy and applied immunology.

[27]  R. Langer,et al.  Formulation and delivery of proteins and peptides , 1994 .

[28]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .